Capricor Therapeutics (CAPR) Net Cash Flow Growth (5y) (2015 - 2026)
Capricor Therapeutics (CAPR) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Capricor Therapeutics |
1.63 Bn |
1.36 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-85.22% |
| Dec 31, 2025 |
153.10% |
| Sep 30, 2025 |
-31.40% |
| Jun 30, 2025 |
-17.51% |
| Mar 31, 2025 |
13.44% |
| Dec 31, 2024 |
-78.38% |
| Sep 30, 2024 |
127.99% |
| Jun 30, 2024 |
41.30% |
| Mar 31, 2024 |
-38.07% |
| Dec 31, 2023 |
89.51% |
| Sep 30, 2023 |
16.27% |
| Jun 30, 2023 |
3.50% |
| Mar 31, 2023 |
2.03% |
| Dec 31, 2022 |
19.66% |
| Sep 30, 2022 |
-84.02% |
| Jun 30, 2022 |
-58.63% |
| Mar 31, 2022 |
105.58% |
| Dec 31, 2021 |
15.80% |
| Sep 30, 2021 |
-22.34% |
| Jun 30, 2021 |
-5.45% |
